Literature DB >> 11306518

Measuring circulating oxidized low-density lipoprotein to evaluate coronary risk.

S Tsimikas, J L Witztum.   

Abstract

Mesh：

Substances：

Year:  2001        PMID： 11306518     DOI： 10.1161/01.cir.103.15.1930

Source DB:  PubMed          Journal:  Circulation        ISSN： 0009-7322            Impact factor:   29.690


× No keyword cloud information.
  16 in total

1.  Relation between plasma oxLDL antibodies and oxLDL in the circulation.

Authors:  Yan Wang; Xueqiang Fang; Shumei Wang; Yueqiu Feng; Jinghai Yin
Journal:  Inflammation       Date:  2006-12-02       Impact factor: 4.092

Review 2.  Oxidized low-density lipoprotein biomarkers in atherosclerosis.

Authors:  Sotirios Tsimikas
Journal:  Curr Atheroscler Rep       Date:  2006-01       Impact factor: 5.113

3.  Monocyte tissue factor-dependent activation of coagulation in hypercholesterolemic mice and monkeys is inhibited by simvastatin.

Authors:  A Phillip Owens; Freda H Passam; Silvio Antoniak; Stephanie M Marshall; Allison L McDaniel; Lawrence Rudel; Julie C Williams; Brian K Hubbard; Julie-Ann Dutton; Jianguo Wang; Peter S Tobias; Linda K Curtiss; Alan Daugherty; Daniel Kirchhofer; James P Luyendyk; Patrick M Moriarty; Shanmugam Nagarajan; Barbara C Furie; Bruce Furie; Douglas G Johns; Ryan E Temel; Nigel Mackman
Journal:  J Clin Invest       Date:  2012-01-03       Impact factor: 14.808

4.  PPARgamma regulates adipocyte cholesterol metabolism via oxidized LDL receptor 1.

Authors:  Patricia C Chui; Hong-Ping Guan; Michael Lehrke; Mitchell A Lazar
Journal:  J Clin Invest       Date:  2005-07-07       Impact factor: 14.808

5.  Circulating soluble lectin-like oxidized low-density lipoprotein receptor-1 levels are associated with proximal/middle segment of the LAD lesions in patients with stable coronary artery disease.

Authors:  Mehmet Balın; Ahmet Celik; M Ali Kobat
Journal:  Clin Res Cardiol       Date:  2011-11-25       Impact factor: 5.460

6.  Detoxification of aldehydes by histidine-containing dipeptides: from chemistry to clinical implications.

Authors:  Zhengzhi Xie; Shahid P Baba; Brooke R Sweeney; Oleg A Barski
Journal:  Chem Biol Interact       Date:  2013-01-09       Impact factor: 5.192

7.  Dietary carnosine prevents early atherosclerotic lesion formation in apolipoprotein E-null mice.

Authors:  Oleg A Barski; Zhengzhi Xie; Shahid P Baba; Srinivas D Sithu; Abhinav Agarwal; Jian Cai; Aruni Bhatnagar; Sanjay Srivastava
Journal:  Arterioscler Thromb Vasc Biol       Date:  2013-04-04       Impact factor: 8.311

8.  Oxidatively modified low-density lipoproteins are potential mediators of proteasome inhibitor resistance in multiple myeloma.

Authors:  Srikanth R Polusani; Valerie Cortez; Javier Esparza; Huynh Nga Nguyen; Hongxin Fan; Gopalrao V N Velagaleti; Matthew J Butler; Marsha C Kinney; Babatunde O Oyajobi; Samy L Habib; Reto Asmis; Edward A Medina
Journal:  Int J Cancer       Date:  2021-03-08       Impact factor: 7.316

Review 9.  Noninvasive assessment of preclinical atherosclerosis.

Authors:  Helen A Lane; Jamie C Smith; J Stephen Davies
Journal:  Vasc Health Risk Manag       Date:  2006

10.  Integrating soluble biomarkers and imaging technologies in the identification of vulnerable atherosclerotic patients.

Authors:  José A Páramo; José A Rodríguez Ja; Josune Orbe
Journal:  Biomark Insights       Date:  2007-02-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.